에 대한 최신 뉴스 Verve Therapeutics (NASDAQ:VERV) 주식

VERVE THERAPEUTICS INC

Verve Therapeutics

Verve Therapeutics Inc clinical-stage company developing a new class of genetic medicines for cardiovascular disease, or CVD, with the potential to transform treatment from chronic therapies to single-course gene editing medicines. The current paradigm of chronic care is fragile requiring rigorous patient adherence, extensive healthcare infrastructure, and regular healthcare access, and leaves many patients without adequate care. Its pipelines are PCSK9, ANGPTL3, and LPA. The group has one reportable segment relating to the research and development of gene-editing medicines. The segment derives its current revenues from research and development collaborations.

Cathie Wood Ark Tesla

Equities

News

Markets

ETFs

ACHR

ARKK

AVAV

BLDE

NTLA

TDOC

TSLA

VERV

수요일에 캐시 우드가 이끄는 아크 인베스트(Ark Invest)는 이 회사의 인상적인 2분기 납품 실적에 힘입은 최근 상승세에도 불구하고 테슬라(NASDAQ:TSLA)의 상당 수의 주식을 매각하여 주목할만한 움직임을 보였다.

아크 인베스트가 예상을 넘는 2분기 배송 실적에도 $3.25백만 규모 테슬라 주식 매도 추가

Cathie Wood

$BTC

ABSI

ARKW

COIN

ROKU

월요일에는 캐시 우드가 주도하는 아크 인베스트(Ark Invest)가 몇 가지 중요한 거래를 했으며, 그 가운데 코인베이스 글로벌(NASDAQ:COIN)의 거래가 주목을 받았다. 이는 특히 암호화폐의 경우 격동적인 시장 시나리오 속에서 발생했다.
코인 거래

아크 인베스트는 비트코인이 $62,000 아래로 하락하면서 코인베이스 주식을 매도

cathie_wood_bz_ark

$ETH

ARCT

ARKF

ARKG

ARKQ

ARKX

HOOD

MKFG

캐시 우드가 이끄는 아크 인베스트(Ark Invest)는 수요일에 로빈후드 마켓(NASDAQ:HOOD) 및 줌 비디오 커뮤니케이션(NASDAQ:ZM)괴 관련하여 상당한 거래를 했다.
로빈후드 주식의 거래

아크 인베스트는 로빈후드 주식 150만 달러를 매도하며, 줌 주식 330만 달러 상당도 처분

Verve Therapeutics Inc

MGI MEDIA & GAMES INVEST by MGI MEDIA & GAMES INVEST SE

Verve Group SE

Flavoring products maker McCormick &amp; Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MKC#NYSE">MKC</a>) shares jumped nearly 6% in Thursday&#8217;s premarket session after the company topped fiscal second quarter 2025 earnings estimates and reaffirmed its full-year outlook, with management highlighting strong positioning to <a target="_blank" href="https://www.benzinga.com/movers" rel="noreferrer noopener">offset tariff-related pressures</a>.
The company reported second-quarter adjusted earnings per share of 69 cents, <a target="_blank" href="https://www.benzinga.com/pressreleases/25/06/n46111391/mccormick-reports-strong-second-quarter-performance-and-reaffirms-2025-outlook" rel="noreferrer noopener">beating the analyst consensus estimate of 66 cents</a>. Quarterly sales of $1.659 billion outpaced the Street view of $1.658 billion.
Net sales increased 1% in the second quarter, driven by volume growth, and included a 1% unfavorable impact from currency. Organic sales growth of 2% was driven by volume.
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/earnings/25/06/46093695/cereal-giant-general-mills-cautious-outlook-offers-little-crunch-stock-falls" rel="noreferrer noopener">Cereal Giant General Mills&#8217; Cautious Outlook Offers Little Crunch, Stock Falls</a>
Consumer segment net sales increased by 3%, while Flavor Solutions segment net sales decreased by 1%.
Adjusted operating income was&nbsp;$258.6 million, 9.7% higher year over year. Adjusted operating margin jumped by 120 basis points year over year to 15.6%.
Adjusted gross profit in the quarter under review inched up by 0.5% to $622.8 million, while adjusted gross margin contracted by 20 basis points to 37.5%.
The company noted that most U.S. imports from Mexico and Canada already comply with the United States-Mexico-Canada Agreement. Its tariff mitigation strategy includes data-driven sourcing plans, cost-saving efforts, and revenue growth management.
&#8220;For this fiscal year, we are well positioned with our robust plans to mitigate current tariff-related costs, fuel growth investments, and expand operating margins,&#8221; said CEO Brendan M. Foley.&nbsp;
The company exited the quarter with cash and equivalents worth $124.1 million, with inventories worth $1.307 billion.
Long-term debt contracted to $3.099 billion, down from $3.593 billion as of November 30, 2024.
For the fiscal year 2025, McCormick reaffirmed its net sales, adjusted operating profit, and adjusted earnings per share outlook. The company projects net sales growth of 0% to 2%, with operating income of 2% to 4%.
The company reaffirmed its full-year 2025 adjusted earnings per share guidance of $3.03 to $3.08, compared to the consensus estimate of $3.04.
Price Action: MKC shares are trading higher by 5.92% to $78.00 premarket at last check Thursday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/equities/25/06/46111186/us-stocks-likely-to-open-higher-despite-powells-tariff-induced-inflation-warning-walgreens-nike-in-focus-ahead-of-earnings" target="_blank" rel="noreferrer noopener">US Stocks Likely To Open Higher Despite Powell&#8217;s Tariff-Induced Inflation Warning: Walgreens, Nike In Focus Ahead Of Earnings</a></li>
</ul>
Photo via Shutterstock

Earnings

Guidance

Movers

General

McCormick Says It Can Mitigate Current Tariff Related Costs, Fuel Growth Investments, Stock Soars

Good Morning Traders! In today&#8217;s Market Clubhouse Morning Memo, we will discuss SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META, and TSLA.
Our proprietary formula, exclusive to Market Clubhouse, dictates these price levels. This dynamic equation takes into account price, volume, and options flow. These levels are updated every day and shared with all Clubhouse Members, prior to the opening of the market.
We recommend closely monitoring these stocks, and be prepared to leverage potential breakouts or reversals. As always, stay alert and ready to adjust your tactics based on the market&#8217;s pulse to optimize your trading gains. Now, let&#8217;s dive into the stock analysis:
SPDR S&amp;P 500 ETF Trust (SPY)
SPY is currently trading around our pivotal level of 609.33. Bulls are aiming to capture momentum early and push the price upward to 610.63. If the market confidently sustains action above 610.63, the next step for buyers will be to secure our key support at 611.39, opening the door for an advance toward 612.68. The bullish stretch target for SPY today stands at 613.46.&nbsp;
On the downside, if SPY struggles to maintain 609.33, bears will quickly pressure lower toward 608.35. Should selling activity persist, watch for further weakness at 607.55. Breaking decisively below this point under strong selling pressure will set the stage for a significant test at 606.34. If the bears dominate today&#8217;s price action, the lower boundary target is set at 605.41.
Invesco QQQ Trust Series 1 (QQQ)
QQQ is actively auctioning near our crucial pivot at 543.22. Bulls need to maintain strength above this point, driving the auction higher to solidify support at 545.14. Continued bullish participation can lead to an advance toward 547.65. A sustained strong auction could propel QQQ to the 550.60 area, with a bullish target set firmly at 553.46.&nbsp;
Should the bulls fail to hold above 543.22, bearish traders will likely seize the initiative, pressing lower aggressively toward 542.31. If sellers gain traction, anticipate a deeper pullback toward 540.60. Persistent selling might further weigh down QQQ to test 539.02, and a breach of this support may open the path toward today&#8217;s low bear target at 538.06.
Apple Inc. (AAPL)
Apple is currently trading close to our significant marker at 200.53. Buyers need to firmly defend this level as support, with initial targets at 202.29. Strengthening bullish interest may accelerate the climb toward 203.48, and if buyers can maintain control throughout today&#8217;s session, expect a bullish push toward the daily target at 204.33. Conversely, failure to hold above 200.53 will likely see bearish momentum intensify, driving prices lower toward 199.51. Continued selling activity would pressure the auction further downward, aiming at 198.79. Increased bearish aggression may extend the decline to 198.22, with our bearish scenario bottoming out at 197.69.
Microsoft Corp. (MSFT)
Microsoft is currently navigating around our critical level of 493.62. Bulls aim to solidify the price action above this area, targeting a move to 495.11 and establishing it as new support during today&#8217;s session. Achieving this would likely stimulate additional bullish moves toward 496.90, potentially extending the rally to the high bull target at 498.27.&nbsp;
If buyers falter at 493.62, expect bearish forces to capitalize swiftly, driving the price down to 491.33. Sustained weakness at this point may lead to further declines toward 489.88. Should sellers maintain control, anticipate an additional downward push toward 488.74, culminating at today&#8217;s low bear target of 487.59.
NVIDIA Corporation (NVDA)
NVIDIA is trading near our key level at 156.49. Buyers are looking for initial bullish strength to reclaim and hold support at 158.34. Success here would encourage upward momentum toward 160.64. Continued buyer enthusiasm could further extend the rally toward 162.15, setting the stage for reaching today&#8217;s ambitious bull target at 164.35.&nbsp;
If NVIDIA fails to sustain above 156.49, sellers may drive the price quickly downward toward 154.64. Should bearish pressure intensify, expect continued declines toward 153.23. A notably weak auction today could result in additional tests at 151.99, potentially pushing the price to our lowest bear target at 150.32.
Alphabet Inc Class A (GOOGL)
Alphabet is actively trading around our pivot level of 172.28. Bulls must firmly establish control here, pushing prices upward toward initial resistance at 174.01. Robust buying interest through the session could carry the auction higher, ultimately targeting our high bull level at 175.12.&nbsp;
On the bearish side, failing to maintain 172.28 could trigger selling momentum down toward 171.14. Continued bearish interest would test the price lower at 169.34. If selling pressure remains heavy, expect a move down toward our bearish session target of 167.04.
Meta Platforms Inc (META)
Meta is currently positioned around our key support at 714.27. For bullish sentiment to prevail, traders need to secure the price action above 716.39 and drive toward resistance at 717.87. Persistent bullish participation could elevate the auction further toward 720.11, ultimately aiming at our daily bullish goal of 721.50.&nbsp;
Conversely, losing the level at 714.27 would signal bearish strength, with selling pressure likely taking the auction lower toward 712.14. If bearish momentum picks up significantly, watch for a continuation lower to test 708.06. A breakdown here could see bears driving the price down further, targeting our daily bearish boundary at 704.07.
Tesla Inc. (TSLA)
Tesla is currently oscillating near our pivotal level of 327.59. Bulls want early confirmation above this level to launch a rally targeting the first resistance at 333.93. Continued buying strength could carry prices higher, first reaching toward 340.97 and, on broader bullish market conditions, potentially hitting the next major resistance at 346.64. Today&#8217;s high-end bullish goal for Tesla is at 350.87.&nbsp;
Should Tesla lose support at 327.59, expect bearish traders to dominate quickly, driving prices lower toward 322.52. Further selling activity may amplify downside momentum, testing 315.93. A decisive break below this area with sustained bearish volume may ultimately take prices down to today&#8217;s low bear target at 312.42.
Final Word: Today is notably eventful, kicking off with the highly anticipated Q1 final Reading of Annualized GDP and the GDP Price Index at 8:30 AM ET. This significant economic data will arrive simultaneously with the Chicago Fed National Activity Index, Preliminary Durable Goods Orders, and the Advance Goods Trade Balance &#8211; all critical indicators for assessing economic strength. Additionally, the Weekly Initial and Continuing Jobless Claims at the same time will provide essential insights into the labor market. Later in the morning, at 10:00 AM ET, traders should watch the Pending Home Sales for May, followed by the Kansas City Fed Manufacturing Activity report at 11:00 AM ET, which offers an important regional economic snapshot. 
Furthermore, today&#8217;s economic schedule is bolstered by several Federal Reserve speakers, including Barkin at 8:00 AM ET, Hammack at 9:00 AM ET, and Barr at 1:15 PM ET, each potentially influencing market sentiment and volatility. Lastly, keep an eye on the 7-Year Note Auction at 1:00 PM ET, as bond market dynamics could spill over into equities. With markets hovering near all-time highs and an intensive calendar of economic releases and Fed commentary, traders should brace for heightened volatility and remain disciplined in their risk management. Good luck and stay sharp today!
For a limited time during our special promotion, you can join RIPS and get a full access pass to Market Clubhouse for 7 full days for just $7. Check it out at <a href="https://marketclubhouse.club/7Days/" title="https://marketclubhouse.club/7Days/">https://marketclubhouse.club/7Days/</a> where you can trade live with him and tap into his wealth of knowledge and experience. You can also catch Rips on his live day trading streams every Monday-Friday at 8 am EST on the Market Clubhouse YouTube channel: <a href="https://www.youtube.com/@MarketClubhouse" title="https://www.youtube.com/@MarketClubhouse">https://www.youtube.com/@MarketClubhouse</a>.

Broad U.S. Equity ETFs

Technicals

Opinion

Signals

Trading Ideas

How To Trade SPY, Top Tech Stocks With GDP Data In Focus

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RVPH#NASDAQ">RVPH</a>) (&quot;Reviva&quot; or the &quot;Company&quot;), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), inflammatory and cardiometabolic diseases, today announced the pricing of its previously announced public offering with existing and new healthcare focused institutional investors for the purchase and sale of 20,000,000 shares of its common stock (or common stock equivalents in lieu thereof) together with Series C warrants to purchase up to 20,000,000 shares of common stock (the &quot;Series C Warrants&quot;) and Series D warrants to purchase up to 20,000,000 shares of common stock (the &quot;Series D Warrants&quot;), at a combined offering price of $0.50 per share and accompanying warrants, for aggregate gross proceeds of approximately $10 million before deducting placement agent fees and other offering expenses.
The Series C Warrants and the Series D Warrants will have an exercise price of $0.50 per share. The Series C Warrants will be exercisable immediately and will expire five years from the issuance date. The Series D Warrants will be exercisable immediately and will expire 12 months from the issuance date.
The closing of the offering is expected to occur on or about June 27, 2025, subject to the satisfaction of customary closing conditions. The Company currently intends to use the net proceeds from the offering to fund research and development activities and for working capital and other general corporate purposes.
A.G.P./Alliance Global Partners is acting as the sole placement agent for the offering.

Offerings

RVPH

Reviva Prices $10M Public Offering Of 20M Shares And Dual Warrants At A Combined Offering Price Of $0.50 Per Share And Accompanying Warrants

WIIM

JFBR

Jeffs' Brands shares are trading higher after the company entered into a securities purchase agreement, under which it may to issue and sell convertible promissory notes in an aggregate principal amount of up to $100 million.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul class="wp-block-list">
<li>HC Wainwright &amp; Co. analyst Brandon Folkes initiated coverage on Eupraxia Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EPRX#NASDAQ">EPRX</a>) with a Buy rating and announced a price target of $12. Eupraxia Pharmaceuticals shares closed at $4.31 on Wednesday. <a href="https://www.benzinga.com/quote/eprx/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JP Morgan analyst Bill Peterson initiated coverage on Centrus Energy Corp. (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/LEU#AMEX">LEU</a>) with a Neutral rating and announced a price target of $148. Centrus Energy shares closed at $181.18 on Wednesday. <a href="https://www.benzinga.com/quote/leu/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Barclays analyst Nicholas Campanella initiated coverage on NRG Energy, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NRG#NYSE">NRG</a>) with an Overweight rating and announced a price target of $197. NRG Energy shares closed at $153.32 on Wednesday. <a href="https://www.benzinga.com/quote/nrg/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Citigroup analyst Asiya Merchant initiated coverage on Sandisk Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNDK#NASDAQ">SNDK</a>) with a Buy rating and announced a price target of $57. SanDisk shares closed at $47.25 on Wednesday. <a href="https://www.benzinga.com/quote/sndk/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Wells Fargo analyst Eva Fortea Verdejo initiated coverage on IDEAYA Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IDYA#NASDAQ">IDYA</a>) with an Overweight rating and announced a price target of $44. IDEAYA Biosciences shares closed at $22.01 on Wednesday. <a href="https://www.benzinga.com/quote/idya/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying NRG stock? Here&#8217;s what analysts think:
<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/quote/NRG/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="601" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/26083538/image-407-1024x601.png" alt="" class="wp-image-963204" style="width:636px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/26083538/image-407-1024x601.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/26083538/image-407-300x176.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/26083538/image-407-768x451.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/26083538/image-407.png 1120w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read This Next:
<ul class="wp-block-list">
<li> <a href="https://www.benzinga.com/trading-ideas/short-ideas/25/06/46093486/top-2-utilities-stocks-that-may-fall-off-a-cliff-in-q2">Top 2 Utilities Stocks That May Fall Off A Cliff In Q2</a> </li>
</ul>
Photo via Shutterstock

Initiation

Pre-Market Outlook

Analyst Ratings

EPRX

IDYA

SNDK

This NRG Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

JP Morgan analyst Samik Chatterjee maintains Apple (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) with a Overweight and lowers the price target from $240 to $230.

Price Target

AAPL

JP Morgan Maintains Overweight on Apple, Lowers Price Target to $230

Jeffs' Brands Enters Securities Purchase Agreement Pursuant To Which Co. May Issue And Sell Convertible Promissory Notes In Aggregate Principal Amount Up To $100M

Dario and GreenKey Join Forces to Target $150 Billion Sleep Apnea Market, Addressing 29 Million Americans with Unmet Needs Through Integrated Chronic Care Solution
NEW YORK and SAN FRANCISCO, June 26, 2025 /PRNewswire/ -- DarioHealth Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRIO#NASDAQ">DRIO</a>) ('Dario' or the 'Company'), a leader in the global digital health market, today announced a strategic commercial agreement with GreenKey Health ('GreenKey'), an innovator in value-based sleep health solutions, to bring the comprehensive care program to payers nationwide. The collaboration leverages the strengths of both companies to deliver a tiered, data-driven solution for improving member health outcomes, reducing healthcare costs, and enhancing productivity through the integration of behavioral health, sleep, and cardiometabolic care. The collaboration targets the $150 billion sleep apnea market affecting over 29 million Americans, with up to 80% of moderate to severe cases currently undiagnosed.

DRIO

DarioHealth Announces Strategic Commercial Agreement With GreenKey Health To Bring Comprehensive Care Program To Payers Nationwide

RELI

Reliance Global Group Highlights Spetner's Q1 Results Revenue Increased 95% YoY To ~$5.16M

HUHU

HUHUTECH International Group To Acquire 100% Of Issued Equity Interest Of Huhu Technologies Deutschland For Total Of ~$28,930

SYPR

Sypris Solutions' Sypris Technologies Enters Into Long-Term Agreement To Supply Certain Drivetrain Components For Global Truck OEM's New Electrified Heavy-Duty Vehicle

Coeptis Therapeutics Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COEP#NASDAQ">COEP</a>) ("Coeptis" or the "Company"), a next-gen technology and biopharmaceutical company, is pleased to announce the filing of a registration statement on Form S-4 with the Securities and Exchange Commission ("SEC") related to the Company's previously announced and proposed definitive merger agreement (the "Merger") with Z Squared Inc. ("Z Squared").
The Form S-4 includes a preliminary proxy statement/prospectus regarding the proposed transaction. The registration statement has not yet become effective, and the information contained therein is subject to change.

COEP

Coeptis Therapeutics Files Form S-4 With SEC For Proposed Merger With Z Squared

AENT

Alliance Entertainment Partners With Master Replicas To Be Exclusive Distribution Partner

JTAI

Jet.AI shares are trading higher after the company announced an agreement with Consensus Core to jointly develop a Phase Hyperscale data center campus in Canada.

Jet.AI  And Consensus Core Announce Agreement To Jointly Develop A Phase Hyperscale Data Center Campus In Canada

On Wednesday, the U.S. Federal Trade Commission (FTC) concluded <a href="https://www.benzinga.com/topic/antitrust">its antitrust review </a>of Mars Incorporated&#8217;s pending acquisition of Kellanova (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/K#NYSE">K</a>).
Mars is a family-owned company in the pet care, snacking, and food industries.
In August 2024, Mars agreed to acquire Kellanova for $36 billion, or <a target="_blank" href="https://www.benzinga.com/m-a/24/08/40376430/mars-to-buy-kellanova-for-36b-snickers-maker-moves-up-a-rank-on-largest-private-company-list" rel="noreferrer noopener">$83.50 per share</a>.
Poul Weihrauch, CEO &amp; Office of the President, Mars, said: &#8220;We are very pleased that the FTC has completed its review of the transaction without the imposition of any condition or requiring any remedy. The transaction has now received all but one of the 28 required regulatory clearances, with only the <a href="https://www.benzinga.com/pressreleases/25/06/b46106697/mars-pending-acquisition-of-kellanova-clears-ftc-antitrust-review" target="_blank" rel="noopener">European Commission&#8217;s review</a><a href="https://www.benzinga.com/pressreleases/25/06/b46106697/mars-pending-acquisition-of-kellanova-clears-ftc-antitrust-review" target="_blank" rel="noreferrer noopener"> outstanding</a>.
Based on the current status of the European Commission&#8217;s ongoing antitrust review, Mars and Kellanova expect the transaction to close by the end of 2025.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/25/04/44961625/fda-targets-synthetic-food-dyes-in-sweeping-nutrition-overhaul" rel="noreferrer noopener">FDA Targets Synthetic Food Dyes In Sweeping Nutrition Overhaul</a>
The exact timing cannot be predicted with any certainty at this point.
On Wednesday, the European Commission <a href="https://ec.europa.eu/commission/presscorner/detail/en/ip_25_1604" target="_blank" rel="noreferrer noopener">opened</a> an in-depth investigation to assess, under the EU Merger Regulation, Mars&#8217; proposed acquisition of Kellanova.
The Commission has preliminary concerns that the transaction could lead to higher prices for consumers due to Mars&#8217; increased negotiating power towards retailers in the European Economic Area.
As a result, Mars could use this increased leverage to, for example, extract higher prices during negotiations, which would, in turn, lead to higher prices for consumers.
The Commission has serious concerns based on these early findings:
<ul class="wp-block-list">
<li>Both companies already have a strong presence in several markets across different EU countries, partly because they sell popular brands that consumers consider essential.</li>
<li>Retailers in the European Economic Area (EEA) are worried that if Mars adds Kellanova's key brands to its lineup, it would gain even more power in negotiations. This could force retailers to agree to higher prices just to keep these must-have products on their shelves.</li>
<li>Since many shoppers prefer to do all their grocery shopping in one store, they might switch to another supermarket if their favorite brands from Mars and Kellanova aren't available.</li>
</ul>
The Commission was notified of the proposed transaction on May 16. It has 90 working days, until Oct. 31, to decide.
Kellanova reported a&nbsp;<a target="_blank" href="https://www.benzinga.com/news/25/05/45139492/kellanova-misses-q1-revenue-and-earnings-estimates-due-to-weak-global-demand-and-currency-pressure" rel="noreferrer noopener">first-quarter FY25 sales decline&nbsp;</a>of 3.6% year-on-year to $3.08 billion, missing the analyst consensus estimate of $3.18 billion.
While net sales were impacted by negative currency translation and widespread category softness, the company sustained organic growth, led again by its emerging markets.
Adjusted EPS of $0.90&nbsp;<a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">missed the consensus</a>&nbsp;estimate of $1.01.
Price Action: K stock is up 1.04% at $78.65 during the premarket session at the last check on Thursday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/macro-economic-events/25/06/46111863/toy-prices-see-unprecedented-surge-as-trump-tariffs-take-a-toll-theres-just-no-escaping-china" target="_blank" rel="noreferrer noopener">Toy Prices See Unprecedented Surge As Trump Tariffs Take A Toll: &#8216;There&#8217;s Just No Escaping China&#8217;</a></li>
</ul>
Photo: Shutterstock

Large Cap

Mars Just Got The Green Light For Its $36B Deal — But Europe Might Blow It Up

Reduction in Force Estimated to Save Over $750K or 23.4% of Annual Payroll Expenses
Agreements Progress Toward Completion; Shareholder Meeting Scheduled for July 24, 2025
IRVINE, Calif., June 26, 2025 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=R7Z8sW8zFDWhFPvX3G5QLKLRU4azwr1KkAlT1kYGgC5rO_j8C7bENzeNkir0k__NRhlZOfkFnCiSI1IQITEJX8dGfUhWs1pe1bf9nAqTPXmo2EoazqPjRbdZcNb7y9B4">ReShape Lifesciences Inc.</a> (NASDAQ:<a href="https://www.benzinga.com/stock/RSLS#NASDAQ">RSLS</a>), the premier physician-led weight loss and metabolic health-solutions company, today announced strategic headcount reduction and provided an update on the merger agreement with Vyome Therapeutics and asset purchase agreement with Biorad Medisys.

RSLS

ReShape Lifesciences Announces Strategic Headcount Reduction; Issues Update On Merger Agreement With Vyome Therapeutics And Asset Purchase Agreement With Biorad Medisys

Dividends

Kroger's Board of Directors Raises Quarterly Dividend From $0.32 To $0.35/Share

Iran, a founding member of OPEC in 1960, <a href="https://europeancapitalinsights.substack.com/p/iran-loses-influence-in-opec-after?r=3nmatg">has lost influence</a> in the oil cartel that provides 36% of the world's production as the Islamic Republic's status eroded over decades due to sanctions and its meddling in the Middle East.
Tehran has 157 billion barrels of proven oil reserves, equivalent to approximately 12% of the global total. Iran exports just under half of its oil output to China through a shadow fleet of aging tankers.
"Iran is not a major OPEC producer any longer," Karen Young, senior fellow at the Middle East Institute, said. "The industry in Iran has suffered from a long-term lack of investment and technology."
At its peak in the 1970s, Iran pumped over 6 million barrels per day (bpd). The<a target="_blank" rel="noreferrer noopener" href="https://www.opec.org/monthly-oil-market-report.html"> OPEC monthly oil report</a> estimated May production at around 3.3 million barrels per day (bpd), out of which it was exporting 1.84 million bpd,<a target="_blank" rel="noreferrer noopener" href="https://www.eia.gov/international/content/analysis/special_topics/SHIP_Act/SHIP-Act.pdf"> mainly to China</a>.
<figure class="wp-block-image"><a href="https://substackcdn.com/image/fetch/$s_!nbAJ!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fd44d260a-a773-4a4d-adb3-ded3685da310_863x417.png" target="_blank" rel="noreferrer noopener"><img decoding="async" src="https://substackcdn.com/image/fetch/$s_!nbAJ!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fd44d260a-a773-4a4d-adb3-ded3685da310_863x417.png" alt="" /></a><figcaption class="wp-element-caption">Iran's oil exports, 2017 vs 2024, Source: S&amp;P Global</figcaption></figure>
<a href="https://x.com/eurocapinsights/status/1938193699730510146">Sanctions have granted Iran</a> exemptions from OPEC+ quotas, but that also means it has no say in shaping the group's output policy. For example, in 2022, members ignored Tehran's call for a bloc-wide oil embargo on Israel.
Still, the Vienna-based cartel remains the best opportunity for the country to engage with the world. "Frankly speaking, OPEC is the one and only diplomatic channel for Iran," a source familiar with its participation<a target="_blank" rel="noreferrer noopener" href="https://www.spglobal.com/commodity-insights/en/news-research/latest-news/crude-oil/061725-feature-iran-diminished-in-opec-no-longer-holds-oil-trump-card"> told</a> Platts back in March.
<h2 class="wp-block-heading">Iran's Isolation Driven by Sanctions, Regional Policies</h2>
Iran's international isolation started in 1979 after the Iranian Revolution. The US, under then-President Jimmy Carter, imposed sanctions after Iranian students stormed the American embassy in Tehran, holding 66 Americans captive for a 444-day hostage crisis.
Since then, the US has imposed additional sanctions that target Iran's economy, nuclear program, and support for terrorism. In June, the Department of the Treasury <a target="_blank" rel="noreferrer noopener" href="https://home.treasury.gov/news/press-releases/sb0175">designated one</a> individual and eight entities for their involvement in the procurement and transshipment of sensitive defense-related machinery to Iran.
"The United States remains resolved to disrupt any effort by Iran to procure the sensitive, dual-use technology, components, and machinery that underpin the regime's ballistic missile, unmanned aerial vehicle, and asymmetric weapons programs," US Secretary of the Treasury Scott Bessent said. "We have been clear: those who enable these schemes will be held accountable."
The US <a target="_blank" rel="noreferrer noopener" href="https://europeancapitalinsights.substack.com/p/trump-arrives-for-nato-summit-europe">attacked Iran's</a> Fordow, Natanz, and Isfahan nuclear plants as part of that effort. The US strikes, codenamed "Operation Midnight Hammer," consisted of 14 30,000lbs GBU-57 "bunker buster" bombs deployed by US B-2 stealth bombers and around 30 Tomahawk missiles fired from US submarines.
<h2 class="wp-block-heading">Insurers Brace For Escalation in Middle East</h2>
The strikes initially sent crude oil prices 23% higher, to $79.60 per barrel, before pulling back 15% following Iran's retaliation. Markets stabilized after Trump announced on <a target="_blank" rel="noreferrer noopener" href="https://truthsocial.com/@realDonaldTrump/posts/114734934153569653">Truth Social</a> on Monday that Israel and Iran have agreed to a &#8220;complete and total ceasefire.&#8221;
Insurance markets are already reacting, assessing the risks from the Strait of Hormuz, to Houthi rebels, to Israeli ports. War risk premiums have surged, particularly for voyages to Israeli ports, where insurance rates have tripled, from 0.2% to 0.7%. The situation reflects the risks that those ports could become collateral damage or direct targets in the event of further escalation.
"We currently consider the threat to the maritime domain to be unchanged but with a negative outlook." David Osler, Lloyd's List Insurance editor, <a target="_blank" rel="noreferrer noopener" href="https://archive.is/nvM5S#selection-1245.0-1245.11">noted</a> last week.
According to a June 18<a target="_blank" rel="noreferrer noopener" href="https://www.argusmedia.com/en/news-and-insights/latest-market-news/2700473-israel-iran-conflict-raises-european-middle-distillates"> report</a> from Argus, a London-based global market analysis firm, European jet fuel and diesel prices are rising due to concerns about a potential supply shortage.
<figure class="wp-block-image"><a href="https://substackcdn.com/image/fetch/$s_!jbpJ!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fb61efc62-f8b5-422b-8a8d-f33241e7d009_1306x691.png" target="_blank" rel="noreferrer noopener"><img decoding="async" src="https://substackcdn.com/image/fetch/$s_!jbpJ!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fb61efc62-f8b5-422b-8a8d-f33241e7d009_1306x691.png" alt="" /></a><figcaption class="wp-element-caption">Low Sulphur ICE Gasoil Futures, year-to-date. Source: TradingView</figcaption></figure>
The report also showed that front-month ICE gasoil futures jumped by a<a target="_blank" rel="noreferrer noopener" href="https://www.argusmedia.com/en/news-and-insights/latest-market-news/2700473-israel-iran-conflict-raises-european-middle-distillates"> record on the day increase</a> of $45.47/t reaching $731/t on June 17. This is the highest daily increase since the Russia-Ukraine war began in February 2022.
Tanker operators are especially wary. Spot rates for VLCCs and LR2s have doubled, and several shipowners, including Frontline, have suspended Gulf transits altogether. Iran, as a precautionary move, has asked ships to leave its ports.
<h2 class="wp-block-heading">GCC States Call for De-Escalation</h2>
While many of OPEC members have issued statements calling for de-escalation after the US strikes, many privately welcomed the US attack against the Islamic Republic. In 2008, former Saudi King Abdullah <a target="_blank" rel="noreferrer noopener" href="https://www.reuters.com/article/world/us-politics/cut-off-head-of-snake-saudis-told-us-on-iran-idUSTRE6AS02B/">called for the</a> US to &#8220;cut off the head of the snake&#8221; in relation to Iran's nuclear program.
Saudi Arabia and the United Arab Emirates, both members of OPEC, consider Iran a rival for regional dominance. Saudi Arabia, the world's largest oil supplier, and Iran have supported opposite sides of conflicts across the Middle East. Iranian-backed Houthi rebels in Yemen have attacked Saudi infrastructure and cargo shipping routes through the Red Sea.
In Syria, Saudi Arabia supported anti-Assad rebel groups, including Sunni factions like the Free Syrian Army and other Islamist groups, with funding, arms, and political backing. Iran, on the other hand, provided military support to the Assad regime until it <a target="_blank" rel="noreferrer noopener" href="https://x.com/AP/status/1865610269449240963">collapsed last year</a>.
Geopolitical rivalries have eroded Iran's role in OPEC and its international standing.
"Iran is totally isolated," ABC News contributor Steve Ganyard <a target="_blank" rel="noreferrer noopener" href="https://x.com/ABC/status/1936596258942067046">said</a>. "They have no friends, they have no allies, they have nobody that&#8217;s going to come to their aid."
<h2 class="wp-block-heading">Iranian Threat to Close Strait of Hormuz Would Alienate Tehran</h2>
Iran has also threatened to close the Strait of Hormuz, where about 20% of the world's<a target="_blank" rel="noreferrer noopener" href="https://youtu.be/JTvf790RWN0?feature=shared"> daily oil supply</a> currently passes, in retaliation for the US airstrikes. The <a target="_blank" rel="noreferrer noopener" href="https://europeancapitalinsights.substack.com/p/trump-arrives-for-nato-summit-europe">narrow passage </a>located off Iran's southern coast serves as the link between the Persian Gulf, the Gulf of Oman, and the wider Arabian Sea.
<figure class="wp-block-image"><a href="https://substackcdn.com/image/fetch/$s_!Rtne!,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fd454fb86-024b-4d2b-a9e6-d3e0894dd728_1320x742.jpeg" target="_blank" rel="noreferrer noopener"><img decoding="async" src="https://substackcdn.com/image/fetch/$s_!Rtne!,w_1456,c_limit,f_auto,q_auto:good,fl_progressive:steep/https%3A%2F%2Fsubstack-post-media.s3.amazonaws.com%2Fpublic%2Fimages%2Fd454fb86-024b-4d2b-a9e6-d3e0894dd728_1320x742.jpeg" alt="" /></a><figcaption class="wp-element-caption">The Strait of Hormuz. Source: <a target="_blank" rel="noreferrer noopener" href="https://www.marketwatch.com/story/strait-of-hormuz-the-worlds-biggest-oil-chokepoint-in-focus-as-us-iran-tensions-flare-2020-01-03">MarketWatch</a></figcaption></figure>
Saudi Arabia uses the strait to export around 6 million barrels of crude oil per day &#8211; more than any neighboring country &#8211; <a href="https://www.bbc.com/news/articles/c78n6p09pzno" target="_blank" rel="noreferrer noopener">according to</a> research by analytics firm Vortexa.
US Secretary of State Marco Rubio has claimed that Iran&#8217;s closure of the strait would amount to &#8220;economic suicide.&#8221; He called on China, an ally of Tehran, to intervene.
Energy analyst Vandana Hari said Iran has &#8220;little to gain and too much to lose&#8221; from closing the Strait of Hormuz. &#8220;Iran risks turning its oil and gas producing neighbors in the Gulf into enemies and invoking the ire of its key market, China, by disrupting traffic in the Strait,&#8221; Hari <a href="https://www.bbc.com/news/articles/c78n6p09pzno" target="_blank" rel="noreferrer noopener">told </a>BBC News.
Disclaimer:
Any opinions expressed in this article are not to be considered investment advice and are solely those of the authors. European Capital Insights is not responsible for any financial decisions made based on the contents of this article. Readers may use this article for information and educational purposes only.&nbsp;
This article is from an unpaid external contributor. It does not represent Benzinga&#8217;s reporting and has not been edited for content or accuracy.

Eurozone

Commodities

Insurance

Iran Loses Influence in OPEC After Years of Sanctions, Regional Meddling

Jefferies analyst Kaumil Gajrawala maintains Clorox (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLX#NYSE">CLX</a>) with a Buy and lowers the price target from $167 to $145.

Jefferies Maintains Buy on Clorox, Lowers Price Target to $145

Press Releases

Verve Therapeutics to Participate in Upcoming Investor Conferences

Verve Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Lilly to acquire Verve Therapeutics to advance one-time treatments for people with high cardiovascular risk

Shareholder Alert: The Ademi Firm Investigates Whether Verve Therapeutics, Inc. Is Obtaining a Fair Price for Its Public Shareholders

Power Metallic (TSX.V: PNPN) Secures Largest Saudi License Amid June 2025 Gold Surge – Material Gains & More Stocks Inside

VERV Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Verve Therapeutics, Inc. Is Fair to Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VERV, SAGE, CTLP, SOAR on Behalf of Shareholders

VERVE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Verve Therapeutics, Inc. - VERV

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VERV, SAGE, CTLP, COLB on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CTLP, VERV, CVAC on Behalf of Shareholders

ACXP

COLB

CTLP

CVAC

PNPNF

PRSO

SAGE

SLRX

SNYR

SOAR

TSXV:PNPN

Akebia Therapeutics

Ardelyx

Anavex Life Sciences Corp. - Common Stock

Anavex Life Sciences

CareDx

Celldex Therapeutics, Inc. - Common Stock

Celldex Therapeutics

Cogent Biosciences

Dynavax Technologies Corporation - Common Stock

Dynavax Technologies

Dyne Therapeutics

89bio

Geron

Janux Therapeutics

MiMedx Group

Mesoblast Limited - American Depositary Shares

Mesoblast

Mineralys Therapeutics, Inc. - Common Stock

Mineralys Therapeutics

MannKind

Anbio Biotechnology - Class A Ordinary Shares

Anbio Biotechnology

Nurix Therapeutics

Intellia Therapeutics, Inc. - Common Stock

Intellia Therapeutics

Novavax

Praxis Precision Medicines, Inc. - Common Stock

Praxis Precision Medicine

Arcus Biosciences

Spyre Therapeutics

Travere Therapeutics, Inc. - Common Stock

Travere Therapeutics

Viridian Therapeutics, Inc. - Common Stock

Viridian Therapeutics

Zymeworks

HC Wainwright & Co.

LifeSci Capital

Jefferies

Canaccord Genuity

Guggenheim

수요일에 캐시 우드가 이끄는 아크 인베스트(Ark Invest)는 이 회사의 인상적인 2분기 납품 실적에 힘입은 최근 상승세에도 불구하고 테슬라(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>)의 상당 수의 주식을 매각하여 주목할만한 움직임을 보였다.
테슬라 주식
아크 인베스트는 ARK Innovation ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKK#NYSE">ARKK</a>)를 통해 테슬라 지분을 줄여 13,213주를 매각했다. 이번 거래는 테슬라의 주가가 최근 화요일에 10.20% 급등해 4월 말 이후 최고의 장중 거래를 기록했다는 점을 감안하면 놀라운 일이었다. 특히 화요일에 아크 인베스트는 <a href="https://www.benzinga.com/markets/equities/24/07/39611275/cathie-woods-ark-invest-sells-tesla-shares-worth-14-5m-amid-rally-driven-by-q2-delivery-numbers-">1,450만 달러</a> 상당의 테슬라 주식을 매각했다.
이러한 상승은 주로 일론 머스크가 이끄는 이 회사의 <a href="https://www.benzinga.com/markets/equities/24/07/39595720/tesla-deliveries-fall-for-second-straight-quarter-but-stock-takes-off-as-q2-numbers-exceed-expec">2분기 실적</a>에 의해 주도되었다. 테슬라는 예상 차량 439,000대를 크게 초과하는 443,956대를 인도했다고 보고했다. 이러한 놀라운 상승세는 랠리를 촉진하여 주가를 2024년 최고치로 끌어올렸다. 판매의 대부분은 저렴한 모델 3 및 Y에서 이루어졌으며, 더 비싼 모델 X, S 및 신형 사이버트럭에서는 21,551대만 판매되었다.
최종 종가 246.39달러를 기준으로 수요일에 판매된 주식의 가치는 약 325만 달러에 달한다. 이날 테슬라 주가는 6.5% 급등했다.
기타 중요한 거래:
<ul>
<li>아크 인베스트의 ARKF 펀드는 텔레닥(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDOC#NYSE">TDOC</a>)의 주식을 팔았다.</li>
<li>ARKG 펀드는 인텔리아 테라퓨틱스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTLA#NASDAQ">NTLA</a>)의 주식을 2,551주 매수하고, 버브 테라퓨틱스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERV#NASDAQ">VERV</a>)의 주를 팔았다.</li>
<li>ARKK 펀드는 아처 에비에이션(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACHR#NASDAQ">ACHR</a>)의 주를 사고, 깅코 바이오웍스 홀딩스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DNA#NYSE">DNA</a>)의 주를 팔았다.</li>
<li>ARKQ 펀드는 에어로바이런먼트(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVAV#NASDAQ">AVAV</a>)의 주를 팔았다. ARKX 펀드는 블레이드 에어 모빌리티(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLDE#NASDAQ">BLDE</a>)의 주를 샀다.</li>
</ul>
이미지는 셧터스톡을 통해 제공됨
이 기사는 <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a>를 사용하여 <a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noreferrer noopener">Shivdeep Dhaliwal</a>이 편집했다

월요일에는 캐시 우드가 주도하는 아크 인베스트(Ark Invest)가 몇 가지 중요한 거래를 했으며, 그 가운데 코인베이스 글로벌(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>)의 거래가 주목을 받았다. 이는 특히 암호화폐의 경우 격동적인 시장 시나리오 속에서 발생했다.
코인 거래
이날 아크 인베스트의 가장 눈에 띄는 거래는 대표적인 암호화폐 거래소 플랫폼인 코인베이스와의 거래였다. 이번 거래는 비트코인(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) ​​가격이 62,000달러 아래로 떨어지는 등 <a href="https://www.benzinga.com/markets/cryptocurrency/24/06/39459091/coinbase-shares-tumble-with-bitcoin-whats-going-on-with-the-stock" target="_blank" rel="noopener" data-google-interstitial="false">암호화폐 시장이 상당한 변동성</a>을 겪고 있는 시기에 이루어졌다. 이러한 비트코인 ​​가격 하락은 코인베이스 주가에 직접적인 영향을 미쳤으며 월요일에도 하락세를 보였다.
코인베이스 주가는 월요일 정규 세션이 끝날 때 212.31달러를 기록했다. 이 회사는 ARK 차세대 인터넷 ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKW#NYSE">ARKW</a>)를 통해 3,341개의 코인베이스 주식을 매도했다. 이 거래 금액은 709,327달러이다.
기타 중요한 거래:
<ul>
<li>텔레닥 헬스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDOC#NYSE">TDOC</a>): ARKG ETF에서 54,256주, ARKK ETF에서 61,606주를 매도했다.</li>
<li>앱사이이(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABSI#NASDAQ">ABSI</a>): ARKG ETF를 통해 43,936주를 매수했다.</li>
<li>버브 테라퓨틱스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERV#NASDAQ">VERV</a>): ARKG ETF에서 10,570주, ARKK ETF에서 50,971주를 매도했다.</li>
<li>로쿠(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROKU#NASDAQ">ROKU</a>): ARKK ETF를 통해 32,989주를 매수했다.</li>
</ul>
다음 읽기: <a href="https://www.benzinga.com/markets/cryptocurrency/24/06/39448829/bitcoin-ethereum-dogecoin-fall-on-investor-worries-analyst-warns-of-king-cryptos-dip-below?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">투자자 우려로 비트코인, 이더리움, 도지코인 가격 하락</a>
이 기사는 <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a>에서 제공한 내용을 바탕으로 <a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noreferrer noopener">Shivdeep Dhaliwal</a>이 수정했습니다.

캐시 우드가 이끄는 아크 인베스트(Ark Invest)는 수요일에 로빈후드 마켓(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>) 및 줌 비디오 커뮤니케이션(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZM#NASDAQ">ZM</a>)괴 관련하여 상당한 거래를 했다.
로빈후드 주식의 거래
아크 인베스트는 Ark Fintech Innovation ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKF#NYSE">ARKF</a>)와 ARK Next Generation Internet ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKW#NYSE">ARKW</a>)를 통해 약 153만 달러 상당의 로빈후드 주식 64,706주를 매각했다. 이러한 움직임은 이 회사가 최근 시장 변동으로 인해 로빈후드의 <a href="https://www.benzinga.com/markets/equities/24/06/39263031/cathie-wood-lead-ark-invest-dumps-7-6m-worth-of-robinhood-shares-amid-gamestop-buzz-bitcoin-chop">보유 지분</a>을 줄인 후에 나온 것이다. 이 회사의 주가는 현재 5월 영업 데이터 발표 이후 상승하고 있다.
특히 로빈후드 거래는 비트코인(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)과 이더리움(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)의 가격이 약간의 상승세를 보였지만 연방준비은행(연준)의 금리 인하에 대한 매파적인 지침으로 인해 <a href="https://www.benzinga.com/markets/cryptocurrency/24/06/39303902/bitcoin-ethereum-dogecoin-fail-to-sustain-uptrend-after-feds-hawkish-guidance-analyst-fore" target="_blank" rel="noopener" data-google-interstitial="false">이 랠리는 지속되지 않았다</a>.
줌 주식 거래
아크 인베스트는 ARKW를 통해 54,165주, 약 330만달러 상당의 줌 주식을 매도했다. 이 결정은 회사가 지난달 <a href="https://www.benzinga.com/news/earnings/24/05/38926994/zoom-q1-earnings-revenue-beat-eps-beat-cash-flow-surges-continued-ai-integration-and-more">매출과 이익 예상치를 뛰어넘는 강력한 1분기 실적을 발표한 </a>이후의 결정이다.
다른 중요한 거래들:
<ul>
<li>아크 인베스트는 마크포지드 홀딩(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MKFG#NYSE">MKFG</a>)의 주식 21,260주를 ARK Autonomous Technology &amp; Robotics ETF(BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKQ#BATS">ARKQ</a>)를 통해 매수했다. 아크 인베스트는 ARK Space Exploration &amp; Innovation ETF(BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKX#BATS">ARKX</a>)를 통해 마크포지드 8,776주를 구매했다.</li>
<li>아크 인베스트는 페이저듀티(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PD#NYSE">PD</a>)의 주식 15,383주를 ARK Innovation ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKK#NYSE">ARKK</a>)를 통해 구매했다. 아크 인베스트는 ARK Genomic Revolution ETF(BATS:<a class="ticker" href="https://www.benzinga.com/stock/ARKG#BATS">ARKG</a>)를 통해 아크투러스 테라퓨틱스 홀딩스(NASDAQ:<a class="items-end ticker-link-wrapper inline-flex" href="https://www.benzinga.com/quote/arct" target="_blank" rel="dofollow noopener" aria-label="Go to Quote Page for ARCT">ARCT</a>)주식 39,589주를 매수했다.</li>
<li>아크 인베스트는 ARKW ETF를 통해 텔레닥 헬스 주식 229,654주를 매도했다. 아크 인베스트는 ARKK ETF를 통해 버브 테라퓨틱스 주식 125,257주를 매도했다. 이 회사는 ARKG ETF를 통해 버브 테라퓨틱스 주식 24,866주를 매도했다.</li>
</ul>
본 기사는 <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a>를 통해 제작되었으며, <a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noreferrer noopener">Shivdeep Dhaliwal</a>이 수정했습니다.

월요일에 캐시 우드가 주도하는 아크 인베스트(Ark Invest)는 로빈후드 마켓(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HOOD#NASDAQ">HOOD</a>)의 지분을 줄이는 중요한 조치를 취했다. 이 결정은 시장 변동 기간 중에 이루어졌으며 이 투자 회사가 자체 포트폴리오를 조정하는 최근 추세를 따랐다.
로빈후드(HOOD) 매매:
로빈후드에서 포지션을 축소하기로 한 아크 인베스트의 결정은 세 가지 ETF를 통해 실행되었다. ARK Fintech Innovation ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKF#NYSE">ARKF</a>)는 31,827주를 매각했고, ARK Innovation ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKK#NYSE">ARKK</a>)와 ARK Next Generation Internet ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKW#NYSE">ARKW</a>)는 각각 215,675주와 76,299주를 매각했다. 월요일 로빈후드의 종가 23.42달러를 기준으로 판매된 주식의 총 가치는 약 760만 달러이다.
로빈후드 주식의 변동성은 <a href="https://www.benzinga.com/news/24/06/39234943/whats-going-on-with-robinhood-stock" target="_blank" rel="noopener">밈 주식 열기가 부활</a>하는 가운데 발생했다. 최근 로빈후드의 CEO 블래디미어 테네브는 게임스탑에 투자한 것으로 유명한 로어링 키티(Roaring Kitty)이라고도 알려진 키스 길(Keith Gill)의 예정된 라이브 스트리밍으로 인한 트래픽 유입을 회사가 처리할 준비가 되었다고 발표했다. 이 회사는 또한 최근 <a href="https://www.benzinga.com/news/24/05/39047461/robinhood-markets-stock-jumps-on-1b-buyback-whats-going-on">10억 달러 규모의 자사주 매입</a>을 발표했는데, 이는 주가 상승 추세에 기여했다.
특히 비트코인(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)과 이더리움(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) 등 주요 코인들이 적자로 거래되면서 <a href="https://www.benzinga.com/markets/cryptocurrency/24/06/39262872/bitcoin-ethereum-dogecoin-remain-choppy-analyst-forecasts-2x-10x-increase-for-king-crypto-" target="_blank" rel="noopener">고르지 못한 암호화폐 시장</a>을 배경으로 거래가 성사됐다.
다른 중요한 거래:
<ul>
<li>이그젝트 사이언스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXAS#NASDAQ">EXAS</a>): ARKG 및 ARKK를 통해 주식 매도.</li>
<li>아크투러스 테라퓨틱스 홀딩스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARCT#NASDAQ">ARCT</a>): ARKG를 통해 주식 매입.</li>
<li>텔라닥 헬스(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDOC#NYSE">TDOC</a>): ARKG를 통해 주식 매도.</li>
<li>인텔리아 테라퓨틱스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTLA#NASDAQ">NTLA</a>): ARKG 및 ARKK를 통해 주식 매입.</li>
<li>버브 테라퓨틱스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERV#NASDAQ">VERV</a>): ARKG 및 ARKK를 통해 주식 매도. 베라사이트(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VCYT#NASDAQ">VCYT</a>): ARKG 및 ARKK를 통해 5,804주 매입.</li>
</ul>
다음 읽어보기: <a href="https://www.benzinga.com/markets/equities/24/06/39246807/investor-naval-ravikant-threatens-to-sell-all-tesla-holdings-if-ceo-musks-pay-plan-is-rejected-b?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">CEO 일자리 대안에 대한 투자자의 협상</a>
이 이야기는 <a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noreferrer noopener">Shivdeep Dhaliwal</a>의 편집을 거쳐 <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a>에 의해 제작되었습니다.

EXAS

VCYT

아크 인베스트가 게임스톱 관련 뉴스와 비트코인 변동성 속에서 로빈후드 주식 $7.6백만 매각

목요일에 캐시 우드가 주도하는 아크 인베스트(Ark Invest)는 아마존닷컴(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>)과 레딧(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>)에서 상당한 거래를 성사시켰으며 두 회사 모두 눈에 띄는 움직임을 보였다.
아마존닷컴 거래:
아크 인베스트의 ARK 차세대 인터넷 ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKW#NYSE">ARKW</a>)는 아마존 주식 53,368주를 매입했다. 이러한 움직임은 Amazon이 최근 760억 달러 규모의 11년 계약의 일환으로 NBA 미디어 권리를 <a href="https://www.benzinga.com/general/sports/24/06/39215473/amazon-makes-prime-bet-on-sports-with-nba-deal-streaming-platform-will-have-content-from-4-major-l">인수</a>한 이후에 나온 것이다. 이러한 전략적 움직임은 아마존 프라임 비디오(Amazon Prime Video) 스트리밍 플랫폼의 가입자 수를 늘릴 것으로 예상된다. 목요일 아마존의 종가 185달러를 기준으로 한 이번 거래 가치는 약 990만 달러이다.
레딧 거래:
별도의 거래에서, 아크 인베스트의 Ark 핀테크 혁신 ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKF#NYSE">ARKF</a>)는 레딧 주식 1,312주를 매입했다. 이번 매입은 레딧이 최근 고객 경험 관리 플랫폼 기업 스프링클(Sprinklr)과의 <a href="https://www.benzinga.com/news/24/06/39208968/whats-going-on-with-reddit-stock-today">확대된 파트너십 발표한</a> 것과 일치한다. 이 파트너십을 통해 스프링클 고객들은 레딧의 전체 광고 제품군에 액세스하고 레딧을 기업 광고 전략에 통합할 수 있다. 레딧의 목요일 종가 63.46달러를 기준으로 한 이 거래의 가치는 약 83,200달러이다.
다른 중요한 거래:
<ul>
<li>아크 인베스의 ARKG 펀드는 인텔리아 테라퓨틱스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTLA#NASDAQ">NTLA</a>) 주식 25,736주를 매입하고, 이그젝트 사이언스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXAS#NASDAQ">EXAS</a>)의 12,602주를 팔았다.</li>
<li>ARKK 펀드는 페이저듀티(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PD#NYSE">PD</a>)의 106,192주를 매입하고, 버브 테라퓨틱스(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERV#NASDAQ">VERV</a>)의 126,699주를 팔았다. ARKW 펀드는 서비스나우(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOW#NYSE">NOW</a>)의 14,121주를 매도했다.</li>
</ul>
다른 중요한 거래를 읽어보세요: <a href="https://www.benzinga.com/markets/equities/24/06/39192292/amc-stock-rises-as-annual-shareholder-meeting-results-roll-in-whats-going-on?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">AMC주가 상승, 연례 주주총회 결과 발표: 무슨 일이?</a>
이 기사는 <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a>에 의해 작성되었으며 <a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noreferrer noopener">Shivdeep Dhaliwal</a>에 의해 편집되었습니다.

AMZN

RDDT

캐시 우드가 이끄는 아크 인베스트는 아마존 주식을 990만 달러 상당 매수, 레딧도 매입

목요일, 캐시 우드(Cathie Wood)가 이끄는 아크 인베스트(Ark Invest)가 같은 날 주식의 긍정적인 시장 실적에도 불구하고 코인베이스 글로벌(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>) 주식을 매각하여 상당한 움직임을 보였다.
COIN의 트레이드
코인베이스 주식을 매각하기로 한 아크 인베스의 결정은 거래 당일 주식의 상승 궤적을 고려할 때 많은 사람들에게 놀라운 일이었다. 특히 비트코인(CRYPTO: <a class="items-end ticker-link-wrapper inline-flex" href="https://www.benzinga.com/quote/btc-usd" target="_blank" rel="dofollow noopener" aria-label="Go to Quote Page for BTC/USD">BTC</a>) ​​및 이더리움(CRYPTO: <a class="items-end ticker-link-wrapper inline-flex" href="https://www.benzinga.com/quote/eth-usd" target="_blank" rel="dofollow noopener" aria-label="Go to Quote Page for ETH/USD">ETH</a>)과 같은 주요 암호화폐는 이 기사 작성  시점에 혼합 거래되었다. 비트코인은 2.7% 높은 67,632.08달러로 나타났고, 이더리움은 0.3% 낮은 3,268.90달러에 거래되었다.
<a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38091237/coinbase-stock-is-rising-thursday-whats-going-on">벤징가</a> 보고서에 따르면 코인베이스 주식은 목요일 상승했다. 이번 거래에 참여한 ETF는 각각 22,690주와 2,972주의 주식을 판매했던 아크 핀테크 이노베이션 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKK#NYSE">ARKK</a>)와 아크 넥스트 제너레이션 인터넷 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKW#NYSE">ARKW</a>)였다. 이 거래의 가치는 최근 249.61달러의 종가에서 약 640만 달러에 해당한다.
재미있는 점은 뉴욕 소재의 금융기관인 오펜하이머 (Oppenheimer)가 코인베이스의 목표 주가를 200달러에서 276달러로 <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38092813/oppenheimer-raises-coinbase-share-price-target-to-276">상향 조정한 날</a>이기도 했다. 이 날의 새로운 목표 가격은 코인베이스의 종가 251.58달러보다 약 10% 높다.
기타 주요 거래:
<ul>
<li>ARKF는 소파이 테크놀로지스(SoFi Technologies Inc) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOFI#NASDAQ">SOFI</a>)와 로블록스 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBLX#NYSE">RBLX</a>)의 주식을 구매.</li>
<li>ARKF는 트윌리오 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TWLO#NYSE">TWLO</a>)의 주식을 판매, ARKG는 10x 지노믹스 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXG#NASDAQ">TXG</a>)와 벌브 테라퓨틱스 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERV#NASDAQ">VERV</a>)의 주식을 구매.</li>
<li>ARKF는 로쿠 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROKU#NASDAQ">ROKU</a>)의 주식을 구매, 트윌리오 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TWLO#NYSE">TWLO</a>)의 주식을 판매.</li>
</ul>
다음 읽기: <a href="https://www.benzinga.com/markets/cryptocurrency/24/04/38063416/chuck-meme-coin-that-aims-to-make-ethereum-great-again-skyrockets-25-800-hours-after-launc?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">이더리움을 다시 위대하게 만드는 CHUCK Meme Coin, 출시 후 25,800% 급등, 도지코인, 시바 이누 (Shiba Inu) 뒤에 숨어</a>

Cryptocurrency

RBLX

SOFI

TWLO

아크 인베스트: 긍정적인 시장 움직임과 분석가의 상향조정에도 코인베이스 주식 $640만 처분

수요일, 캐시 우드의 아크 인베스트가 핀터레스트 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PINS#NYSE">PINS</a>)의 추가 주식을 구매하는 것으로 눈에 띄는 움직임을 보였다.
핀터레스트의 거래
아크 인베스트의 핀테크 이노베이션 ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKF#NYSE">ARKF</a>)는인기 소셜 미디어 웹사이트이자 메타 플랫폼이 소유한 인스타그램 및 X와 같은 플랫폼의 경쟁사인 핀터레스트의 주식 26,925주를 인수했다. 이 움직임은 핀터레스트의 금융 상황이 복합적인 가운데 이루어졌지만, 최근 <a href="https://www.benzinga.com/news/earnings/24/02/37019165/pinterest-q4-earnings-revenue-miss-eps-beat-monthly-active-users-up-11-and-more">4분기 실적</a> 보고서에서 보여준 유망한 사용자 성장을 바탕으로 한다. 이 거래의 가치는 동일 날 35.28달러의 종가를 바탕으로 하여 949,914달러이다.
아크 인베스트가 핀터레스트에 관심을 보이는 것은 이번이 처음이 아니다. 지난 2월에도 이 투자 기관은 4분기 실적에서의 혼란에도 불구하고 이 회사의 잠재력에 대한 자신감을 증명하기 위해 2,300만달러 이상의 핀터레스트 주식을 구매했다. 최근에 이루어진 이번 구매는 아크 인베스트의 핀터레스트 보유 지분을 더욱 확고히 했다.
기타 중요한 거래들:
아크 인베스트핀테크 이노베이션 ETF에서 트윌리오 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TWLO#NYSE">TWLO</a>)의 주식을 팔았다. 이 회사는 또한 게노믹 리볼루션 ETF를 위해 벌브 테라퓨틱스(Verve Therapeutics Inc) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERV#NASDAQ">VERV</a>)와 퍼스널리스(Personalis Inc) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSNL#NASDAQ">PSNL</a>)의 주식을 구매했다.
넥스트 제너레이션 인터넷(Next Generation Internet) ETF에서는 트윌리오의 주식을 팔고 데이터독(Datadog Inc) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DDOG#NASDAQ">DDOG</a>)의 주식을 샀다.
N/A

DDOG

PINS

PSNL

캐시 우드의 아크 인베스트는 메타 플랫폼 경쟁사의 주식을 추가 매입

Comments

Verve Therapeutics

뉴스

에 대한 최신 뉴스 Verve Therapeutics (NASDAQ:VERV) 주식

목요일, 7월 04, 2024

화요일, 6월 25, 2024

목요일, 6월 13, 2024

화요일, 6월 11, 2024

금요일, 6월 07, 2024

금요일, 4월 05, 2024

목요일, 4월 04, 2024

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌